Pulmonary Manifestation of Crohn's Disease Developed Under Treatment With Vedolizumab.

MLA

Lissner, Donata, et al. “Pulmonary Manifestation of Crohn’s Disease Developed Under Treatment With Vedolizumab.” The American Journal of Gastroenterology, vol. 113, no. 1, Jan. 2018, pp. 146–48. EBSCOhost, https://doi.org/10.1038/ajg.2017.395.

APA

Lissner, D., Glauben, R., Allers, K., Sonnenberg, E., Loddenkemper, C., Schneider, T., & Siegmund, B. (2018). Pulmonary Manifestation of Crohn’s Disease Developed Under Treatment With Vedolizumab. The American Journal of Gastroenterology, 113(1), 146–148. https://doi.org/10.1038/ajg.2017.395

Chicago

Lissner, Donata, Rainer Glauben, Kristina Allers, Elena Sonnenberg, Christoph Loddenkemper, Thomas Schneider, and Britta Siegmund. 2018. “Pulmonary Manifestation of Crohn’s Disease Developed Under Treatment With Vedolizumab.” The American Journal of Gastroenterology 113 (1): 146–48. doi:10.1038/ajg.2017.395.